Abano Healthcare, the medical investor fending off a hostile takeover from its biggest shareholder, posted a 75 per cent jump in full-year profit, beating guidance and allowing it to maintain dividend payments for a sixth straight year.
Profit climbed to $6.1 million in the year ended May 31, from $2.8 million a year earlier, the Auckland-based company said in a statement. Sales climbed 2 per cent to $274 million.
That's the second year in a row that profit has climbed 75 per cent and the company said today it expects to list earnings again in 2015, allowing it to lift dividends starting in the first half of the current year. The shares rose 1.5 per cent to $6.15 and are rated a 'buy' based on two analysts who follow the stock, having declined about 3.5 per cent this year while the nation's benchmark stock index gained.
Abano's trans-Tasman dental business was the biggest contributor to revenue growth in the latest year, along with the company's Australian audiology joint venture and it said today that "growth through acquisitions is still the key focus for the dental sector as we build scale in this very large and attractive market."
"The increasing size of the dental group is providing a stronger negotiating position with suppliers and more economies of scale are being achieved," it said.